on EoE and IBD
Meeting Details


6:45pm – 9:10pm


16 Phillip Street, Sydney 2000
Presented by:



AGENDA
RSVP: Please RSVP by Friday 18 July 2025
Parking: Please proceed to the car park entry for included on-site Self Parking.

Contacts: Britt Rowles on 0468 309 368 or britt.rowles@drfalkpharma.com.au OR
Sylvia Gobran on 0438 234 804 or sylvia.gobran@drfalkpharma.com.au OR
Niki Carfino on 0401 955 399 or niki.carfino@drfalkpharma.com.au
SPEAKERS

Prof. Dr. Luc Biedermann has been a board-certified specialist for Gastroenterology & Hepatology and Internal Medicine since 2012. His special focus as a clinician in the Department of Gastroenterology & Hepatology of the University Hospital Zurich (USZ), Switzerland, is Inflammatory Bowel Disease (IBD), Eosinophilic Oesophagitis (EoE) and other immune mediated gastrointestinal diseases. Since 2017 he has been head of IBD and EoE within the USZ department of Gastroenterology & Hepatology. His main clinical and research interests include epidemiology, natural history and course of disease, environmental factors, intestinal microbiota as well as drug development and clinical trials in IBD and EoE. Regarding EoE, it has been his pleasure for many years to host Prof. Dr. Alex Straumann, who first described EoE in 1994 (simultaneously and independently with Prof. Steven Attwood), for an intensive research collaboration and joint specialised unique outpatient EoE clinic at the USZ.

Dr Sudarshan Paramsothy is a Consultant Gastroenterologist & Hepatologist with a subspecialty interest in inflammatory bowel disease. He completed an NHMRC postgraduate scholarship-funded PhD evaluating faecal microbiota transplantation (FMT) in ulcerative colitis and subsequently undertook post-doctoral Advanced IBD fellowships at both the University of Chicago Medicine Hospital and Mount Sinai Hospital New York. He is now based at Concord Repatriation General Hospital, Sydney, co-managing their IBD service. He is an NHMRC Emerging Leadership Fellow and remains active in IBD teaching, supervision and research, involved in collaborative clinical and translational research studies in IBD, FMT and the gastrointestinal microbiota.

Prof Peter Katelaris has had a multifaceted career. He has been a clinical academic gastroenterologist, researcher, teacher and mentor. He has been active in national and international working parties, clinical guideline formulation, clinical governance and collegiate activity over many years. Throughout his career he has also been involved in voluntary work to improve standards of digestive disease healthcare in the Indo-Pacific region.
Professor Katelaris is one of only two gastroenterologists in Australia ever to have been a recipient of the three major career awards of GESA, namely the Young Investigator Award, The Outstanding Clinician Award and the Inaugural Fellowship of the Society.
He is recognised by his peers as an experienced senior clinician, endoscopist, researcher, mentor and educator.
REGISTRATION FORM
* indicates required fields
Please direct any questions to Britt Rowles on 0468 309 368 or britt.rowles@drfalkpharma.com.au OR
Sylvia Gobran on 0438 234 804 or sylvia.gobran@drfalkpharma.com.au OR
Niki Carfino on 0401 955 399 or niki.carfino@drfalkpharma.com.au
After registering, you will receive a confirmation email which can be saved directly into your calendar.
This meeting is for Healthcare Professionals only. In registering for this meeting, I understand that Personal information collected from me by Dr Falk Pharma Australia when I respond to this invitation will be used for communication about this meeting and other Dr Falk Pharma Australia initiatives. Your personal information will be treated in accordance with applicable laws and in accordance with Dr Falk Pharma Australia policies. For more information, please contact our Privacy Officer by email at privacy@drfalkpharma.com.au or phone 1800 373 255. Copyright © 2025 Dr Falk
Dr. Falk Pharma Australia Pty Ltd. ABN 40 631 091 131. 9 Help Street, Chatswood NSW 2067. Website: www.drfalkpharma.com.au Tel: 1800 DRFALK (1800 373 255). Email: admin@drfalkpharma.com.au
Date of preparation: June 2025. DRF376. COR-2025-1500.